Keeping blood sugar in balance can be a challenge, especially for people with type 1 diabetes who rely on intensive insulin therapy to prevent blood sugar from going too high. At Baylor College of Medicine, the group of Dr. Yong Xu and his colleagues from other institutions study glucose-sensing neurons in the brain and they have identified a novel neural feedback system in a small brain region that contributes to keeping blood sugar in balance.
“Glucose-sensing neurons sense fluctuations in blood sugar levels and respond by rapidly decreasing or increasing their firing activities. This response can trigger changes in behavior to increase glucose levels. For instance, the animals may begin eating,” said Xu, professor of pediatrics-nutrition at Baylor and the USDA-ARS Children’s Nutrition Research Center (CNRC) at Baylor and Texas Children’s Hospital. “Glucose-sensing neurons also can affect the production of hormones such as glucagon that can directly regulate glucose production or uptake by peripheral tissues. It’s a feedback system that keeps the balance of blood glucose.”
Glucose-sensing neurons are found in several brain regions. Xu and his colleagues focused on neurons located in a small area called the ventrolateral subdivision of the ventromedial hypothalamic nucleus (vlVMH). Many neurons in this region express estrogen receptor-alpha and respond to glucose fluctuations in the blood, but their functions in glucose metabolism had not been specifically investigated.
A unique population of neurons
The researchers found that neurons in the vlVMH nucleus of murine brains had unique characteristics.
First, Xu and his colleagues were surprised that, while in other VMH subdivisions about half of the neurons were glucose-sensing, in the ventrolateral subdivision all the estrogen receptor-alpha neurons were glucose-sensing. “Just this fact makes this group of neurons quite unique,” said Xu, who also is professor of molecular and cellular biology at Baylor.
They also found that, although all the neurons in this area sense glucose, they do not respond to changes in glucose level in the same way. About half of the neurons are ‘glucose-excited’ – their firing activity increases when they sense high glucose levels and decreases when glucose levels are low. In contrast, the other half of the neurons are glucose-inhibited – they decrease firing when glucose is high and increase it when glucose is low.
“We wondered why these neurons responded in opposite ways to the same glucose challenge,” Xu said.
The researchers combined genetic profiling, pharmacological, electrophysiological and CRISPR gene-editing approaches to look into this question. They investigated the ion channels that each type of glucose-sensing neuron uses to respond to glucose levels. Ion channels are large molecules spanning across the cell membranes of neurons. The channels control the traffic of ions – electrically charged atoms or molecules – in and out of neurons, a process that is crucial for regulating neuronal firing activities.
The researchers found that glucose-excited neurons use a KATP ion channel, but the glucose-inhibited neurons used a different ion channel called Ano4.
The KATP ion channel is well known in our field, but the role of Ano4 ion channel in glucose sensing has never been reported. We have identified a new ion channel that is important for glucose-inhibited neurons,” Xu said.
A coordinated effect regulates blood glucose
In addition, Xu and colleagues identified the neuronal circuits that are involved when glucose-excited and glucose-inhibited neurons respond to low blood glucose levels. They discovered that the circuits were different – glucose-excited neurons project neuronal connections to a brain region that is different from the one reached by glucose-inhibited neurons.
Using optogenetics, a combination of genetic modifications and light to activate specific neuronal circuits, the researchers showed in mice that when glucose-inhibited neurons responded to low glucose levels, they activated a particular circuit, and the result was an increase of blood glucose. On the other hand, when glucose-excited neurons responded to low blood glucose, they inhibited a different circuit, but the result also was an increase in blood glucose levels.
“When the mice were hypoglycemic, these two circuits were regulated in an opposite manner – one was excited while the other was inhibited – but the outcome was the same, bringing blood glucose to normal levels,” Xu said. “This forms a perfect feedback system to regulate blood glucose levels.”
Interestingly, all the neurons in this important group express estrogen receptor-alpha, a well-known mediator of the ovarian hormone, estrogen. In the future, Xu and colleagues want to investigate whether estrogen plays a role in the glucose-sensing process and whether there are gender differences in the functions of these neurons on glucose balance.
Would you like to know more about this work? Find it in the journal Nature Communications.
Other contributors to this work include Yanlin He, Pingwen Xu, Chunmei Wang, Yan Xia, Meng Yu, Yongjie Yang, Kaifan Yu, Xing Cai, Na Qu, Kenji Saito, Julia Wang, Ilirjana Hyseni, Matthew Robertson, Badrajee Piyarathna, Min Gao, Sohaib A. Khan, Feng Liu, Rui Chen, Cristian Coarfa, Zhongming Zhao, Qingchun Tong and Zheng Sun. The authors are affiliated with one or more of the following institutions: Baylor College of Medicine, University of Cincinnati, the University of Texas Health Science Center at San Antonio and the University of Texas Health Science Center at Houston.
This work was supported by grants from the NIH (R01 DK114279 and R21NS108091, R01ES027544/DK111436, R01DK100697, R00DK107008 and K01 DK119471), John S. Dunn Foundation and Clifford Elder White Graham Endowed Fund and USDA/CRIS (3092-5-001-059). Further support was provided by American Diabetes Association (1-17-PDF-138 and 1-15-BS-184) and American Heart Association awards (17GRNT32960003 and 19CDA34660335). Single cell transcriptome profiling was conducted at the Single Cell Genomics Core at BCM that is partially supported by shared instrument grant from NIH (S10OD018033, S10OD023469, S10OD025240) and data were analyzed by the BCM Multi-Omics Data Analysis Core (P01DK113954). This work also was partially supported by the Cancer Prevention and Research Institute of Texas (CPRIT, RP170005 and RP180734) and the NCI Cancer Center Support Grant (P30CA125123).
